Download PDF
CC BY-NC-ND 4.0 · Journal of Child Science 2018; 08(01): e43-e45
DOI: 10.1055/s-0038-1655752
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Growth Hormone Deficiency in Congenital Toxoplasmosis

Juma Natsheh
1   Department of Pediatrics, Endocrinology Unit, Makassed Islamic Hospital, Jerusalem, Israel
,
Bassam Abu-Libdeh
1   Department of Pediatrics, Endocrinology Unit, Makassed Islamic Hospital, Jerusalem, Israel
,
Abdulsalam Abu-Libdeh
1   Department of Pediatrics, Endocrinology Unit, Makassed Islamic Hospital, Jerusalem, Israel
› Author Affiliations
Further Information

Publication History

19 June 2017

18 April 2018

Publication Date:
25 May 2018 (online)

   Permissions and Reprints

Abstract

Congenital toxoplasmosis represents the second most commonly recognized congenital infection. Ocular and neurological abnormalities are considered the most frequent sequelae. Endocrinological manifestations are rare and have received little attention. We report a 3.5-month-old female infant who presented with failure to thrive and recurrent hypoglycemic attacks, diagnosed as growth hormone deficiency due to sequelae of congenital toxoplasmosis. Although endocrinological sequelae of congenital toxoplasmosis are uncommon, they represent potentially treatable conditions. Here, we stress on the importance of monitoring pituitary function and growth in children in particular, with congenital toxoplasmosis, keeping in mind other possible, potentially treatable, endocrinological manifestations.

Keywords

congenital toxoplasmosis - hypothalamopituitary dysfunction - growth hormone deficiency
 

  • References

  • 1 Bale Jr JF. Fetal infections and brain development. Clin Perinatol 2009; 36 (03) 639-653
    CrossrefPubMedGoogle Scholar
  • 2 McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis?. Mem Inst Oswaldo Cruz 2009; 104 (02) 320-344
    CrossrefPubMedGoogle Scholar
  • 3 Carruthers VB, Suzuki Y. Effects of Toxoplasma gondii infection on the brain. Schizophr Bull 2007; 33 (03) 745-751
    CrossrefPubMedGoogle Scholar
  • 4 Kravetz J. Congenital toxoplasmosis. BMJ Clin Evid 2008; 2008: 906
    PubMedGoogle Scholar
  • 5 Massa G, Vanderschueren-Lodeweyckx M, Van Vliet G, Craen M, de Zegher F, Eggermont E. Hypothalamo-pituitary dysfunction in congenital toxoplasmosis. Eur J Pediatr 1989; 148 (08) 742-744
    CrossrefPubMedGoogle Scholar
  • 6 Lopes FM, Gonçalves DD, Mitsuka-Breganó R, Freire RL, Navarro IT. Toxoplasma gondii infection in pregnancy. Braz J Infect Dis 2007; 11 (05) 496-506
    PubMedGoogle Scholar
  • 7 Wolfe SM, Sawitz WG, Paschkis KE. Pituitary dwarfism and toxoplasmosis. J Clin Endocrinol Metab 1955; 15 (06) 745-753
    CrossrefPubMedGoogle Scholar
  • 8 Suresh Babu PS, Nagendra K, Navaz RS, Ravindranath HM. Congenital toxoplasmosis presenting as hypogonadotropic hypogonadism. Indian J Pediatr 2007; 74 (06) 577-579
    CrossrefPubMedGoogle Scholar
  • 9 Stahl W, Kaneda Y. Aetiology of thyroidal dysfunction in murine toxoplasmosis. Parasitology 1998; 117 (Pt 3): 223-227
    CrossrefPubMedGoogle Scholar
  • 10 Nitta A, Suzumura H, Kano K, Arisaka O. Congenital toxoplasmosis complicated with central diabetes insipidus in the first week of life. J Pediatr 2006; 148 (02) 283
    PubMedGoogle Scholar